Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Schott (Chicago, United States of America), C. Ascoli (Chicago, United States of America), Y. Huang (Chicago, United States of America), D. Perkins (Chicago, United States of America), P. Finn (Chicago, United States of America). Diminished peripheral T cell activity in sarcoidosis associates with progressive disease.. 2156

Member's Comments

No comment yet.

Related content which might interest you: Levels of CD4CD25 T regulatory cells in bronchial mucosa and peripheral blood of chronic obstructive pulmonary disease indicate involvement of autoimmunity mechanisms Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Decreased TCR γδ T lymphocytes in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003 Pulmonary dendritic cells from chronic obstructive pulmonary disease patients suppress lung immune responses through induction of regulatory T cells Source: Annual Congress 2011 - T-cell subsets Year: 2011 Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis Source: Eur Respir J 2016; 48: 1171-1183 Year: 2016 Decreased mitochondrial complex I activity in blood lymphocytes of patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Regulator and effector T lymphocytes in late stages of non small cell lung cancer and chronic obstructive pulmonary disease Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 The role of increasing TIM3 on T cells in patients with nontuberculous mycobacterial lung disease: from immune cell dysfunction to clinical severity Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021 Lung dendritic cells from chronic obstructive pulmonary disease patients induce type 1 T regulatory cells Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma Year: 2012 Correlation between the lymphocytes metabolic enzymes activity and the expression of some T cell surface markers in BAL fluid of sarcoid patients with different disease activity Source: Eur Respir J 2005; 26: Suppl. 49, 551s Year: 2005 The role of regulator and effector T lymphocytes in chronic obstructive pulmonary disease and lung cancer Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Rapid decline in lung function in COPD is associated with decreased CD25brightFoxP3 regulatory T cells in BAL Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Cytokine releasing mucosa-homing T cells are increased in peripheral blood of pulmonary fibrosis patients Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Regulatory T cells and inhibitory receptor expression in chronic pulmonary aspergillosis patients Source: International Congress 2017 – From microbiology to clinical work Year: 2017 High percentage of CD8+ effector T lymphocytes in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 A high probability of short-range interactions between fibrocytes and CD8+ T cells potentiates the inflammatory response in chronic obstructive pulmonary disease (COPD) lungs Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 Deterioration of regulatory B cells and activation of follicular helper T cells in idiopathic interstitial pneumonias patients Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 Peripheral blood myeloid-derived suppressor cells reflect disease status in IPF Source: ERS Lung Science Conference 2016 Year: 2016 Differences in alveolar cell populations, natural killer cells and lymphocyte subsets between pulmonary sarcoidosis (PS) and idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006 Antigen-specific multifunctional T-cells in sarcoidosis patients with Löfgren’s syndrome Source: Eur Respir J 2012; 40: 110-121 Year: 2012 Predicting prognosis of lung function decline in IPF using gene expression in peripheral blood mononuclear cells Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017